Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan Hcl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Journal article

Open access

O.S. Aljitawi, S. Ganguly, S. Abhyankar, K. Wolfe, K. Daniels, M. Ferree, R. Marks, W. Kramer, J.D. Pipkins and J.P. McGruirk

Biology of blood and marrow transplantation, Vol.18(2), pp.S257-S257

01/02/2012

Files and links (1)

url

https://doi.org/10.1016/j.bbmt.2011.12.155View

Published (Version of record) Open

1 Record Views

Title: Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan Hcl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Creators - without role: O.S. Aljitawi - University of Kansas Medical Center
S. Ganguly - University of Kansas Medical Center
S. Abhyankar - University of Kansas Medical Center
K. Wolfe - The University of Kansas Cancer Center
K. Daniels - The University of Kansas Cancer Center
M. Ferree - Clinipace
R. Marks - Clinipace
W. Kramer - Massanutten Regional Library
J.D. Pipkins - Ligand Pharmaceuticals
J.P. McGruirk - University of Kansas Medical Center
Publication Details: Biology of blood and marrow transplantation, Vol.18(2), pp.S257-S257
Publisher: Elsevier Inc
Identifiers: 9945794408331
Academic Unit: King Abdullah University of Science & Technology
Language: English
Resource Type: Journal article